<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent studies have strongly implicated the excitatory neurotransmitter <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> in the cascade of pathological mechanisms that cause <z:hpo ids='HP_0002529'>neuronal loss</z:hpo> after certain types of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The neurotoxic effects of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> are mediated, at least in global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, via <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study we have examined the effects of compounds that possess <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> properties (ifenprodil, SL 82.0715 [(+/-)-alpha-(4-chlorophenyl)-4-[(4-fluorophenyl)<z:chebi fb="36" ids="29309">methyl</z:chebi>]- 1-piperidineethanol] and 1-[1-(<z:chebi fb="0" ids="35849">2-thienyl</z:chebi>)<z:chebi fb="0" ids="52552">cyclohexyl</z:chebi>]<z:chebi fb="0" ids="18049">piperidine</z:chebi>) on the histological consequences of focal, as opposed to global, <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in both the rat and the cat </plain></SENT>
<SENT sid="3" pm="."><plain>Ifenprodil (0.3-3 mg/kg i.v.) administered as a perfusion over 3 hr after occlusion of the feline middle cerebral artery reduced the volume of infarcted tissue (measured 4 days after occlusion) in a dose-related manner </plain></SENT>
<SENT sid="4" pm="."><plain>At the highest dose a 42% reduction of infarcted volume was noted, essentially in cortical tissue </plain></SENT>
<SENT sid="5" pm="."><plain>In an identical protocol, a derivative of ifenprodil, SL 82.0715, reduced the volume of infarction in a manner comparable to that described for ifenprodil </plain></SENT>
<SENT sid="6" pm="."><plain>As SL 82.0715 possesses better p.o. bioavailability, this compound was also evaluated in the rat, again after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>First administered 30 min after the induction of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, SL 82.0715 (1 and 10 mg/kg p.o.) reduced infarction volume by 34 and 48%, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>The quantitative histology was performed 2 days after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>The noncompetitive receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, 1-[1-(<z:chebi fb="0" ids="35849">2-thienyl</z:chebi>)<z:chebi fb="0" ids="52552">cyclohexyl</z:chebi>]<z:chebi fb="0" ids="18049">piperidine</z:chebi>, administered (1 mg/kg i.p.) before the induction of focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, similarly and significantly decreased the final volume of infarction </plain></SENT>
<SENT sid="10" pm="."><plain>As both ifenprodil and SL 82.0715 are noncompetitive <z:chebi fb="68" ids="48706">antagonists</z:chebi> of the <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor, two conclusions may be drawn from the present investigation </plain></SENT>
<SENT sid="11" pm="."><plain>First, <z:chebi fb="0" ids="31882">NMDA</z:chebi> antagonism by ifenprodil and its derivative is an effective approach for tissue sparing in animal models of <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Second, these pharmacological observations provide evidence for the involvement of excitatory amino-acid induced-neurotoxicity in the evolution and consequences of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>